Investigational Site Number : 0360001

Richmond, Victoria 3121

1 studies enrolling now · 2 studies all time

What they study most

Plasma Cell Myeloma Recurrent, Plasma Cell Myeloma Refractory

Studies at this site

• Isatuximab in Combination With Novel Agents in RRMM - Master Protocol — Recruiting now
• SC Versus IV Isatuximab in Combination With Pomalidomide and Dexamethasone in RRMM — Running, not enrolling